It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Bioapplication is an emerging field of metal-organic frameworks (MOF) utilization, but biocompatible MOFs with permanent porosity are still a rarity in the field. In addition, biocompatibility of MOF constituents is often overlooked when designing bioMOF systems, intended for drug delivery. Herein, we present the a Zn(II) bioMOF based on vitamin C as an independent ligand (bioNICS-1) forming a three-dimensional chiral framework with permanent microporosity. Comprehensive study of structure stability in biorelavant media in static and dynamic conditions demonstrates relatively high structure resistivity, retaining a high degree of its parent specific surface area. Robustness of the 3D framework enables a slow degradation process, resulting in controllable release of bioactive components, as confirmed by kinetic studies. BioNICS-1 can thus be considered as a suitable candidate for the design of a small drug molecule delivery system, which was demonstrated by successful loading and release of urea—a model drug for topical application—within and from the MOF pores.
Metal–organic frameworks have demonstrated great potential as drug delivery systems, but the biocompatibility of the MOF components is often overlooked. Here, a vitamin C and zinc-based MOF with permanent microporosity is designed, and successful loading and release of model drug urea from the MOF pores, as well as degradation of the framework, are demonstrated.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 National Institute of Chemistry, Ljubljana, Slovenia (GRID:grid.454324.0) (ISNI:0000 0001 0661 0844); University of Ljubljana, Faculty of Inorganic Chemistry and Technology, Ljubljana, Slovenia (GRID:grid.8954.0) (ISNI:0000 0001 0721 6013)
2 Stockholm University, Stockholm, Sweden (GRID:grid.10548.38) (ISNI:0000 0004 1936 9377)
3 Ruđer Bošković Institute, Zagreb, Croatia (GRID:grid.4905.8) (ISNI:0000 0004 0635 7705)
4 National Institute of Chemistry, Ljubljana, Slovenia (GRID:grid.454324.0) (ISNI:0000 0001 0661 0844)
5 National Institute of Chemistry, Ljubljana, Slovenia (GRID:grid.454324.0) (ISNI:0000 0001 0661 0844); University of Nova Gorica, Nova Gorica, Slovenia (GRID:grid.438882.d) (ISNI:0000 0001 0212 6916)